使用心脏症溶液进行药理性除的临床用处
K Kurogochi1, Y Nii2, A Chen2
1JASMINE Veterinary Cardiovascular Medical Center, 1-8-37 Nakagawa, Tsuzuki, Yokohama, Kanagawa, 224-0001, Japan; Department of Clinical Sciences, North Carolina State University, College of Veterinary Medicine, Raleigh, NC, 27607, USA.
概括
药理除疗法有效地解决了狗中心室的再注血. 平均剂量为4. 0毫升/ 千克,可用于治疗狗中风性的单次治疗.
科学领域:
- 兽医心脏病学
- 心血管外科
- 狗的医学
背景情况:
- 在狗的开放心脏手术中,复发性心房动 (VF) 是一个常见的并发症.
- 在犬类手术中,标准的药理除技术尚未得到充分应用.
- 狗中关节的修复为研究关节管理提供了一个相关的临床场景.
研究的目的:
- 评估正在进行中枢修复的狗体中药理除的临床效用.
- 确定晶体心肌的疗效,以治疗再注血性心肌.
- 在该患者群体中确定再注射VF的预测因子.
主要方法:
- 对402只客户拥有的狗进行关节修复的回顾性分析.
- 在交叉释后出现心室动 (VF) 的病例的调查.
- 通过大动脉根导管给予40mEq/ L的晶体心,用于药理性除.
主要成果:
- 在交叉释后,心室动发生在17. 6%的病例中 (70/397).
- 在没有电动干预的情况下,药理除成功地解决了VF.
- 一次剂量心 (中位数为3. 90毫升/ 千克) 在45例有效;24例需要多次剂量.
结论:
- 药理除是一种可行且有效的选择,用于治疗狗中心膜的再输血.
- 平均剂量大约为4. 0毫升/ 千克,单剂量心肌的成功.
- 较低剂量的心可能需要多次注射才能成功进行除.
相关概念视频
Cardiomyopathy II: Dilated Cardiomyopathy
22
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Cardiopulmonary Resuscitation IV: Pharmacological Management
75
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
75
Mitral Stenosis III: Medical Management
21
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
21
Mitral Regurgitation III: Medical Management
30
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
30
Cardiomyopathy V: Interprofessional Care
33
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33


